BridgeMD
Compares treatment options for Acute Ischemic Stroke
Official title Endovascular Therapy Versus Best Medical Treatment for Acute Large Vessel Occlusion Stroke With Low NIHSS
ClinicalTrials.gov ID: NCT06143488
What this study is testing
What is Best medical management?
Best medical management is an investigational medicine, being studied as a potential treatment for acute ischemic stroke.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Patients presenting with mild symptoms of acute ischemic stroke are common and account for approximately half of all acute ischemic stroke. About 30% of patients with minor stroke have a 90-day functional disability.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Aged 18 years or older;
- The time from onset of acute ischemic stroke to arterial puncture is within 24 hours. Onset time is defined as the patient's Last Known Well (LKW);
- Low NIHSS score (2-5 points), with at least one of the following items:
- Altered mental status (lethargy or worse);
- Facial palsy (facial weakness score ≥ 1 point);
See the full eligibility criteria
- Aged 18 years or older;
- The time from onset of acute ischemic stroke to arterial puncture is within 24 hours. Onset time is defined as the patient's Last Known Well (LKW);
- Low NIHSS score (2-5 points), with at least one of the following items:
- Altered mental status (lethargy or worse);
- Facial palsy (facial weakness score ≥ 1 point);
- Motor dysfunction (limb weakness score ≥ 1 point);
- Aphasia (language disturbance score ≥ 1 point);
- Hemispatial neglect (neglect score ≥ 1 point);
- Intracranial internal carotid artery, proximal M1 or M2 segment of middle cerebral artery occlusion (excluding tandem lesions) confirmed by cerebral CTA/MRA/DSA before randomization, which is identified as the culprit...
- All patients receive CTP/MR perfusion imaging, with a volume of perfusion delay (Tmax\>6 s) ≥ 50 mL;
- Written informed consent is obtained from the patient or legal surrogate, with agreement for long-term follow-up.
The study team makes the final eligibility decision.
Where it's taking place
- Wuhu, Anhui, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Wuhu, Anhui, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.